Department of Obstetrics and Gynecology, Affiliated Hospital of Weifang Medical University, No. 2428, Yuhe Road, Weifang, 261042, China.
Department of Obstetrics and Gynecology, Beijing Chao-yang Hospital, Capital Medical University, No.8, North Road of Workers Stadium, Chaoyang District, Beijing, 100020, China.
Diagn Pathol. 2021 Feb 19;16(1):13. doi: 10.1186/s13000-021-01072-9.
The consistency of pathologists in the diagnosis of cervical intraepithelial neoplasia (CINs) is not ideal, especially between low- and high-grade squamous intraepithelial lesions (LSIL and HSIL). This study was aimed to explore efficient strategies for the grading of CINs.
The medical records of patients with high risk human papillomavirus (HR-HPV) infections who had underwent cervical biopsy or conization from April 2018 to April 2019 in Beijing Chao-Yang Hospital were collected and examined. The HR-HPV E6/E7 mRNA in the tissues of patients with CINs was detected using RNAscope chromogenic in situ hybridization (RISH). Immunohistochemistry (IHC) was performed to evaluate the expression of p16INK4a (P16) and Ki67.
HR-HPV E6/E7 mRNA signals were detected in 3/27 (11.1 %) of CIN 1, and in 32/33 (97.0 %) of CIN 2/3. Most of the staining patterns (27/32, 84.4 %) had a full-thickness epithelial layer staining with weak-to-strong nuclear and cytoplasmic dot-like signals in CIN 2/3, and there were also few special staining patterns that were significantly different from the others. A number of indicators were compared between LSIL and HSIL. There were statistically significant differences in E6/E7 mRNA, p16, Ki67 and cytology between the two groups (P < 0.05). According to the logistic regression analysis, merely E6/E7 mRNA positivity was significantly associated with CIN2/3 (OR: 52.53, 95 % CI, P < 0.05). In the detection of CIN 2/3, the sensitivity and specificity of HPV E6/E7 mRNA alone was not significantly inferior to that of its different combinations with Ki67, p16 and cytology (all, P > 0.05).
RISH is efficient in grading of CINs. The HPV E6/E7 mRNA expression might reflect the phase HPV infections, and its positive pattern might predict the development direction of CINs, providing the possibility to realize more accurate treatments for patients.
病理学家在诊断宫颈上皮内瘤变(CIN)时一致性并不理想,尤其是在低级别鳞状上皮内病变(LSIL)和高级别鳞状上皮内病变(HSIL)之间。本研究旨在探索 CIN 分级的有效策略。
收集 2018 年 4 月至 2019 年 4 月在北京朝阳医院因高危型人乳头瘤病毒(HR-HPV)感染行宫颈活检或宫颈锥切术的患者病历进行检查。采用 RNAscope 显色原位杂交(RISH)检测 CIN 患者组织中 HR-HPV E6/E7 mRNA 的表达,免疫组化(IHC)检测 p16INK4a(P16)和 Ki67 的表达。
在 3/27(11.1%)的 CIN1 中检测到 HR-HPV E6/E7 mRNA 信号,在 33/33(97.0%)的 CIN2/3 中检测到 HR-HPV E6/E7 mRNA 信号。CIN 2/3 的大部分染色模式(27/32,84.4%)具有全层上皮层染色,核和细胞质点状信号弱至强,也存在少数特殊染色模式,与其他模式明显不同。比较 LSIL 和 HSIL 之间的多个指标。两组间 E6/E7 mRNA、p16、Ki67 和细胞学均有统计学差异(P<0.05)。根据 logistic 回归分析,仅 E6/E7 mRNA 阳性与 CIN2/3 显著相关(OR:52.53,95%CI,P<0.05)。在检测 CIN 2/3 时,HPV E6/E7 mRNA 单独检测的敏感性和特异性并不明显低于其与 Ki67、p16 和细胞学的不同组合(均 P>0.05)。
RISH 是一种有效的 CIN 分级方法。HPV E6/E7 mRNA 的表达可能反映 HPV 感染的阶段,其阳性模式可能预测 CIN 的发展方向,为实现更准确的患者治疗提供了可能。